World Life Science and Chemical Instrumentation Market - Opportunities and Forecasts, 2015 - 2020

World Life Science and Chemical Instrumentation Market - Opportunities and Forecasts, 2015 - 2020

Category : Diagnostic and Biotech




TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

Life science and chemical instrumentation is used in research & development activities in industrial laboratories, biotechnology industry, pharmaceutical industries, and academic institutes. It is also used in testing the quality of food products, laboratory information management system, and monitor & control process in manufacturing plants. The chemical properties and composition is studies with the help of life science and chemical instrumentation. Thus, these instruments play significant role in scientific analysis of living organism in biotechnology and molecular biology.

Favorable government policies for pharmaceutical R&D in emerging nations and growing food safety concerns fuels the growth of the world life science and chemical instrumentation market. In addition, technological advancements in analytical devices supplements growth. However, high cost of instruments and presence of alternative technologies are factors restraining the growth of the market. On the other hand, growing proteomics market, increasing environmental safety concerns, and demand from applied markets are creating opportunities in the market. 

The world life science and chemical instrumentation market is segmented based on technology, end users, and geography. The technology segment is further classified into chromatography, DNA sequencers & amplifiers, electrophoresis, lab automation, spectroscopy, microarray, flow cytometry, immunoassay, and other instruments. Other instruments include incubators, fume hoods, lab balances, and centrifuges. End users covered in the report are pharmaceutical, biopharmaceutical, & biotechnology companies, clinical research organizations, academic institutions, hospitals, clinics, & diagnostic laboratories, forensic science laboratories, food & agriculture industry, and environmental testing industry. The market is divided geographically into North America, Europe, Asia-Pacific, and Latin America, Middle East and Africa (LAMEA).

The prominent companies operating in the market are Agilent Technologies Inc., Bio-Rad Laboratories Inc., Becton, Dickinson, & Company, Bruker Corporation, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., PerkinElmer Inc., Danaher Corporation, Shimadzu Corporation, and Waters Corporation. Some of the key strategies adopted by these prominent manufacturers to strengthen their position in the market are partnerships, mergers & acquisitions, expansions, joint ventures, collaborations, and others.

KEY BENEFITS FOR STAKEHOLDERS:

  • The report offers an extensive analysis of key driving and restraining factors of the world life science and chemical instrumentation market. 
  • This report offers an in-depth quantitative analysis of the current market and estimations through 2015-2020, which assists in identifying the prevailing market opportunities. 
  • The report provides an extensive analysis of current and future market status of the world life science and chemical instrumentation market.
  • An in-depth analysis of key strategies adopted by leading manufacturers helps in understanding competitive scenario.
  • A comprehensive analysis of current research and clinical developments within the world life science and chemical instrumentation market is provided with key market dynamic factors that helps in understanding the behaviour of the market.
  • Competitive intelligence (of leading manufacturers and distributors of plasma fractionation) helps in understanding the competitive scenario across geographies.
  • Geographically, the world life science and chemical instrumentation market is segmented into North America, Asia-Pacific, Europe, and Latin America, Middle East and Africa (LAMEA).

KEY MARKET SEGMENTS:

  • The Life Science and Chemical Instrumentation Market – By Technology
  • Chromatography 
  • DNA Sequencers & Amplifiers 
  • Electrophoresis 
  • Lab Automation 
  • Spectroscopy 
  • Microarray 
  • Flow Cytometry 
  • Immunoassay 
  • Other Instruments
  • Incubators 
  • Fume Hoods 
  • Lab Balances 
  • Centrifuges
  • The Life Science and Chemical Instrumentation Market – By End User
  • Pharmaceutical, Biopharmaceutical, & Biotechnology Companies 
  • Clinical Research Organizations 
  • Academic Institutions 
  • Hospitals, Clinics, & Diagnostic Laboratories 
  • Forensic Science Laboratories 
  • Food & Agriculture Industry 
  • Environmental Testing Industry
  • The Life Science and Chemical Instrumentation Market – By Geography
  • North America  
  • Asia-Pacific 
  • Europe 
  • Latin America, Middle East and Africa (LAMEA)

Key Market Players:

  • Agilent Technologies Inc. 
  • Bio-Rad Laboratories Inc. 
  • Becton, Dickinson, & Company 
  • Bruker Corporation 
  • Thermo Fisher Scientific Inc. 
  • F. Hoffmann-La Roche Ltd. 
  • Illumina Inc. 
  • PerkinElmer Inc. 
  • Danaher Corporation 
  • Shimadzu Corporation 
  • Waters Corporation

Table Of Contents 1 INTRODUCTION 23 1.1 OBJECTIVES OF THE STUDY 23 1.2 MARKET DEFINITION 23 1.3 MARKET SCOPE 24 1.3.1 MARKETS COVERED 24 1.3.2 YEARS CONSIDERED FOR THE STUDY 27 1.4 CURRENCY 27 1.5 STAKEHOLDERS 27 2 RESEARCH METHODOLOGY 28 2.1 RESEARCH DATA 28 2.1.1 SECONDARY DATA 28 2.1.1.1 Key data from secondary sources 29 2.1.1 PRIMARY DATA 29 2.1.1.1 Breakdown of primaries 30 2.1.1.2 Key data from primary sources 30 2.1.1.3 Key industry insights 31 2.2 MARKET SIZE ESTIMATION 31 2.2.1.1 Bottom-up approach 32 2.2.1.2 Top-down approach 32 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 33 2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS 35 2.4.1 ASSUMPTIONS 35 2.4.2 LIMITATIONS 35 3 EXECUTIVE SUMMARY 36 3.1 INTRODUCTION 36 3.2 CURRENT SCENARIO 37 3.3 FUTURE OUTLOOK 38 3.4 CONCLUSION 40 4 PREMIUM INSIGHTS 41 4.1 ATTRACTIVE OPPORTUNITIES IN THE LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET 41 4.2 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET GROWTH RATE, BY TECHNOLOGY AND REGION (2014–2019) 42 4.3 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY TECHNOLOGY AND REGION, 2014 ($MILLION) 43 4.4 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY TECHNOLOGY, 2012–2019 ($MILLION) 44 5 MARKET OVERVIEW 45 5.1 INTRODUCTION 46 5.2 MARKET SEGMENTATION 46 5.2.1 BY TECHNOLOGY 47 5.2.2 BY END USER 47 5.3 MARKET DYNAMICS 48 5.3.1 DRIVERS 49 5.3.1.1 Increasing government spending on pharmaceutical R&D in emerging nations 49 5.3.1.2 Growing food safety concerns 50 5.3.1.3 Technological advancements in analytical devices 50 5.3.1.4 Funding sources increase the purchasing power of major research institutions 51 5.3.2 RESTRAINTS 52 5.3.2.1 High cost of instruments 52 5.3.2.2 Presence of alternative technologies 52 5.3.3 OPPORTUNITIES 53 5.3.3.1 Emerging markets offering lucrative growth opportunities 53 5.3.3.2 Growing proteomics market 53 5.3.3.3 Growing environmental safety concerns 54 5.3.3.4 Increasing demand from applied markets 55 5.3.3.5 Opportunity for lab automation solutions in biobank applications 55 5.3.4 CHALLENGES 56 5.3.4.1 Extensive requirements in developing chromatography systems that generate pressures of above 20,000 psi 56 5.3.4.2 Survival of small players in the lab automation market 56 5.3.4.3 Adoption and implementation of MIQE guidelines for publishing qPCR- and dPCR–based research 56 6 INDUSTRY INSIGHTS 57 6.1 INTRODUCTION 57 6.2 VALUE CHAIN ANALYSIS 57 6.3 INDUSTRY TRENDS 58 6.3.1 RISING FOCUS OF MARKET PLAYERS TOWARDS THE DEVELOPMENT OF MINIATURIZED INSTRUMENTS 58 6.3.2 INCREASING ADOPTION OF HYPHENATED TECHNOLOGIES 58 6.3.3 TIE-UPS BETWEEN ANALYTICAL INSTRUMENT MANUFACTURERS AND RESEARCH LABORATORIES/ACADEMIC INSTITUTIONS 59 6.4 PORTER’S FIVE FORCES ANALYSIS 59 6.4.1 THREAT OF NEW ENTRANTS 60 6.4.2 THREAT FROM SUBSTITUTES 61 6.4.3 BARGAINING POWER OF SUPPLIERS 61 6.4.4 BARGAINING POWER OF BUYERS 61 6.4.5 INTENSITY OF COMPETITIVE RIVALRY 62 7 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY TECHNOLOGY 63 7.1 INTRODUCTION 64 7.2 CHROMATOGRAPHY 65 7.2.1 DRIVERS 66 7.2.1.1 New international GMP & GDP certification for pharmaceutical excipients (North America & Europe): EXCiPACT 66 7.2.1.2 Industry support to research laboratories and academic institutes 67 7.2.1.3 Rise in government investments in chromatography technologies 67 7.2.1.4 Increased importance of chromatography tests in drug approvals 67 7.2.2 RESTRAINT 68 7.2.2.1 High cost of instruments 68 7.2.3 CHALLENGE 68 7.2.3.1 Obtaining identical results from UHPLC after transfer of HPLC to UHPLC 68 7.2.4 CHROMATOGRAPHY MARKET, BY TYPE 69 7.2.4.1 Liquid chromatography 69 7.2.4.2 Gas chromatography 70 7.2.4.3 Other chromatography techniques 71 7.2.5 MARKET SHARE ANALYSIS, BY KEY PLAYER 72 7.3 ELECTROPHORESIS 72 7.3.1 DRIVERS 74 7.3.1.1 Preferred technique for fragile molecules and variants 74 7.3.1.2 Increase in demand for 2D gel electrophoresis 74 7.3.1.3 Lab-on-a-Chip (LOC) technology 74 7.3.2 RESTRAINT 74 7.3.2.1 Alternative technologies provide better results 74 7.3.3 ELECTROPHORESIS MARKET, BY TYPE 75 7.3.3.1 Gel electrophoresis 75 7.3.3.2 Capillary electrophoresis 75 7.4 DNA SEQUENCERS & AMPLIFIERS 76 7.4.1 DRIVERS 77 7.4.1.1 Technological advancements 77 7.4.1.2 Increasing public and private investments, funds, and grants 78 7.4.1.3 Rising incidence of infectious diseases and genetic disorders 78 7.4.2 RESTRAINTS 79 7.4.2.1 High cost of equipment 79 7.4.3 DNA SEQUENCERS & AMPLIFIERS MARKET, BY TYPE 80 7.4.3.1 DNA sequencers 80 7.4.3.1.1 Market share analysis, by key player 81 7.4.3.2 DNA amplifiers 81 7.4.3.2.1 Thermal Cyclers 82 7.4.3.2.2 Real-time PCR 83 7.4.3.2.3 Others 83 7.5 LAB AUTOMATION 84 7.5.1 DRIVERS 86 7.5.1.1 Process miniaturization leading to low reagent cost and high productivity 86 7.5.1.2 Progress in drug discovery and clinical diagnostics 86 7.5.1.3 Large workforce demand and supply gap 87 7.5.1.4 Greater productivity and reduction in costs 87 7.5.1.5 Smaller volumes of samples and reagents required 87 7.5.2 RESTRAINTS 87 7.5.2.1 Automation not a priority for small- and medium-sized labs 87 7.5.2.2 Indefinite data interchange/communication standards 87 7.5.3 LAB AUTOMATION MARKET, BY TYPE 88 7.5.3.1 Automatic liquid handling 88 7.5.3.2 Microplate readers 88 7.5.3.3 Standalone robots 89 7.5.3.4 Automated storage and retrieval systems 90 7.5.3.5 Software and informatics 90 7.5.3.6 Others 92 7.5.4 MARKET SHARE ANALYSIS, BY KEY PLAYER 93 7.6 SPECTROSCOPY 93 7.6.1 DRIVERS 95 7.6.1.1 Global alliances amongst leading research institutes to boost drug discovery 95 7.6.1.2 Atomic absorption spectroscopy to aid in the drug safety process 95 7.6.1.3 Increasing life science R&D spending 95 7.6.2 RESTRAINTS 96 7.6.2.1 High costs restrict purchase 96 7.6.2.2 Need for skilled professionals 96 7.6.3 SPECTROSCOPY MARKET, BY TYPE 96 7.6.3.1 Molecular spectroscopy 96 7.6.3.1.1 Market share analysis, by key player 97 7.6.3.2 Atomic spectroscopy 97 7.6.3.2.1 Market share analysis, by key player 98 7.6.3.3 Mass spectrometry 99 7.6.3.3.1 Market share analysis, by key player 99 7.7 IMMUNOASSAY 100 7.7.1 DRIVERS 102 7.7.1.1 Rising incidence of chronic and infectious diseases in emerging economies 102 7.7.1.2 Increasing number of approvals for immunoassay techniques 104 7.7.1.3 Advantages such as high sensitivity, low cost, and faster turnaround times 104 7.7.1.4 Increasing health awareness 105 7.7.2 RESTRAINTS 105 7.7.2.1 Low detection restricts adoption of immunoassay tests 105 7.7.2.2 Pricing pressure for some tests due to competition from lower cost-per-test technologies 105 7.7.3 IMMUNOASSAY MARKET, BY TYPE 105 7.7.3.1 Enzyme immunoassay (EIA) 105 7.7.3.2 Fluorescence immunoassay (FIA) 106 7.7.3.3 Chemiluminescence immunoassay (CLIA) 107 7.7.3.4 Radioimmunoassay (RIA) 107 7.7.3.5 Others 108 7.7.4 MARKET SHARE ANALYSIS, BY KEY PLAYER 109 7.8 MICROARRAY 110 7.8.1 DRIVERS AND OPPORTUNITIES 111 7.8.1.1 Growth in personalized medicine 111 7.8.1.2 Technological advances 111 7.8.1.3 Increasing application areas 111 7.8.2 RESTRAINT 112 7.8.2.1 Lack of technical know-how 112 7.8.3 MICROARRAYS MARKET, BY TYPE 112 7.8.3.1 DNA microarrays 112 7.8.3.2 Protein microarrays 112 7.8.3.3 Tissue microarrays 113 7.8.3.4 Cell microarrays 113 7.9 FLOW CYTOMETRY 114 7.9.1 DRIVERS 116 7.9.1.1 Technological advancements in flow cytometry instruments 116 7.9.1.2 Fostering use of flow cytometry techniques in research activities 116 7.9.1.3 Increasing use of flow cytometry in clinical trials 117 7.9.1.4 Increasing use of flow cytometry in HIV and cancer research 117 7.9.1.5 Launch of new reagents for specific applications like diagnostics and drug discovery 117 7.9.2 RESTRAINTS 118 7.9.2.1 High cost of instruments 118 7.9.2.2 Reluctance among researchers in emerging countries to use flow cytometry 118 7.9.2.3 Lack of awareness and dearth of training 118 7.9.3 FLOW CYTOMETRY MARKET, BY TYPE 118 7.9.3.1 Cell-based flow cytometry 118 7.9.3.2 Bead-based flow cytometry 119 7.9.3.3 Others 120 7.9.4 MARKET SHARE ANALYSIS, BY KEY PLAYER 121 7.10 OTHER INSTRUMENTS 121 7.10.1 CENTRIFUGES 122 7.10.2 LABORATORY BALANCES 123 7.10.2.1 Driver 123 7.10.2.1.1 Technological advancements in laboratory balances 123 7.10.2.2 Challenge 123 7.10.2.2.1 Effect of environmental disturbances 123 7.10.3 INCUBATORS 124 7.10.3.1 Drivers 124 7.10.3.1.1 Genetic engineering will drive the market 124 7.10.3.1.2 Stem cells and biological therapeutics increase the demand for CO2 incubators 124 7.10.3.2 Challenge 124 7.10.3.2.1 Contamination – A Major Concern 124 7.10.4 FUME HOODS 125 7.10.4.1 Driver 125 7.10.4.1.1 Improvements in device structure 125 7.10.4.2 Restraint 125 7.10.4.2.1 High electricity consumption 125 8 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY END USER 126 8.1 INTRODUCTION 127 8.2 CHROMATOGRAPHY 127 8.2.1 PHARMACEUTICAL COMPANIES AND CROS 129 8.2.2 BIOTECHNOLOGY AND BIOPHARMACEUTICAL COMPANIES 129 8.2.3 ACADEMIC RESEARCH LABORATORIES 130 8.2.4 AGRICULTURE & FOOD INDUSTRY 131 8.2.5 ENVIRONMENTAL TESTING 131 8.2.6 OTHERS 132 8.3 ELECTROPHORESIS 132 8.3.1 PHARMACEUTICAL COMPANIES AND CROS 133 8.3.2 BIOTECHNOLOGY COMPANIES AND LIFE SCIENCE RESEARCH INSTITUTIONS 133 8.3.3 FORENSIC SCIENCE AND CLINICAL DIAGNOSTIC LABORATORIES 134 8.3.4 ACADEMIC INSTITUTIONS 134 8.3.5 OTHERS 134 8.4 DNA SEQUENCERS & AMPLIFIERS 135 8.4.1 PHARMA & BIOTECH COMPANIES AND CROS 136 8.4.2 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES 136 8.4.3 HOSPITALS AND DIAGNOSTIC CENTERS 137 8.4.4 FORENSIC SCIENCE LABORATORIES 137 ? 8.5 LAB AUTOMATION 137 8.5.1 PHARMA & BIOTECH COMPANIES AND CROS 139 8.5.2 HOSPITALS AND PRIVATE LABS 139 8.5.3 RESEARCH INSTITUTIONS 140 8.5.4 ACADEMIC INSTITUTIONS 140 8.6 SPECTROSCOPY 140 8.6.1 PHARMACEUTICAL COMPANIES AND CROS 142 8.6.2 BIOTECHNOLOGY AND BIOPHARMACEUTICAL COMPANIES 142 8.6.3 ENVIRONMENTAL TESTING 143 8.6.4 FOOD AND BEVERAGE INDUSTRY 143 8.6.5 INDUSTRIAL CHEMISTRY 144 8.6.6 ACADEMIC INSTITUTIONS 144 8.6.7 OTHERS 145 8.7 IMMUNOASSAYS 145 8.7.1 HOSPITALS (PRIVATE/PUBLIC) 146 8.7.2 LABORATORIES (PRIVATE/PUBLIC) 146 8.7.3 PHARMACEUTICAL & BIOTECH COMPANIES AND CROS 147 8.7.4 ACADEMIC INSTITUTIONS 147 8.7.5 OTHERS 147 8.8 MICROARRAYS 148 8.8.1 PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY 149 8.8.2 RESEARCH LABORATORIES 149 8.8.3 DIAGNOSTIC LABORATORIES 149 8.8.4 ACADEMIC INSTITUTIONS 150 8.8.5 OTHERS 150 8.9 FLOW CYTOMETRY 150 8.9.1 COMMERCIAL ORGANIZATIONS 151 8.9.2 ACADEMIC INSTITUTIONS 151 8.9.3 HOSPITALS 152 8.9.4 CLINICAL TESTING LABS 152 8.9.5 MEDICAL SCHOOLS 153 8.10 OTHER INSTRUMENTATION 154 8.10.1 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES AND CROS 154 8.10.2 RESEARCH LABORATORIES 154 8.10.3 ACADEMIC INSTITUTIONS 154 8.10.4 OTHERS 154 9 GLOBAL LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY REGION 155 9.1 INTRODUCTION 156 9.2 NORTH AMERICA 158 9.2.1 FUNDING IN MEDICAL RESEARCH MAY DEVELOP NEW APPLICATION AREAS FOR ANALYTICAL TECHNOLOGIES 159 9.2.2 DRUG DEVELOPMENT REGULATIONS IN NORTH AMERICA 159 9.2.3 GROWING METABOLOMICS RESEARCH IN THE U.S. 160 9.2.4 CONFERENCES, DISCUSSIONS, SYMPOSIUMS, & SEMINARS 160 9.2.5 RISING PREVALENCE OF CHRONIC DISEASES AND AGING POPULATION 161 9.3 EUROPE 166 9.3.1 DIRECT AND INDIRECT FINANCIAL INVESTMENTS IN ANALYTICAL INSTRUMENTS 167 9.3.2 STRATEGIC ALLIANCES IN EUROPE TO TRIGGER THE GROWTH OF DRUG DISCOVERY 167 9.3.3 BURGEONING GROWTH OF THE EUROPEAN BIOSIMILARS MARKET 168 9.3.4 CONFERENCES AND SYMPOSIA 168 9.3.5 DEVELOPING PHARMACEUTICAL SECTOR IN RUSSIA 168 9.4 ASIA-PACIFIC 173 9.4.1 STRATEGIC EXPANSIONS BY KEY MARKET PLAYERS IN EMERGING ASIAN COUNTRIES 174 9.4.2 GROWING PHARMACEUTICAL INDUSTRY IN INDIA AND CHINA 174 9.4.3 EXTENSIVE CROP RESEARCH IN ASIA 175 9.4.4 GOVERNMENT INVESTMENTS IN THE BIOMEDICAL INDUSTRY IN CHINA 175 9.4.5 INFRASTRUCTURAL DEVELOPMENT IN VIETNAM 175 9.4.6 SINGAPORE, AN IMPORTANT MARKET FOR LIFE SCIENCE AND CHEMICAL INSTRUMENTATION 176 9.4.7 CONFERENCES, EXHIBITIONS, & MEETINGS ON ANALYTICAL INSTRUMENTS 176 9.5 REST OF THE WORLD 181 9.5.1 FLOURISHING BIOTECHNOLOGY & PHARMACEUTICAL MARKETS IN BRAZIL AND MEXICO 181 9.5.2 INCREASING R&D FUNDING IN THE LATIN AMERICAN REGION 181 9.5.3 HIGH PREVALENCE OF HIV IN AFRICAN REGION IS LIKELY TO OPEN NEW GROWTH POTENTIAL FOR THE LAB AUTOMATION, IMMUNOASSAY, AND PCR MARKETS 182 10 COMPETITIVE LANDSCAPE 187 10.1 INTRODUCTION 187 10.1.1 NEW PRODUCT LAUNCHES 189 10.1.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 190 10.1.3 EXPANSIONS 191 10.1.4 ACQUISITIONS 192 10.1.5 OTHER DEVELOPMENTS 193 11 COMPANY PROFILES 195 (Overview, Financials, Products & Services, Strategy, & Developments)* 11.1 INTRODUCTION 195 11.2 AGILENT TECHNOLOGIES, INC. 196 11.3 BECTON, DICKINSON AND COMPANY 204 11.4 BIO-RAD LABORATORIES, INC. 208 11.5 BRUKER CORPORATION 213 11.6 DANAHER CORPORATION 218 11.7 F. HOFFMANN-LA ROCHE LTD. 224 11.8 PERKINELMER, INC. 228 11.9 SHIMADZU CORPORATION 233 11.10 THERMO FISHER SCIENTIFIC, INC. 239 11.11 WATERS CORPORATION 247 *Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies. 12 APPENDIX 253 12.1 INSIGHTS OF INDUSTRY EXPERTS 253 12.2 DISCUSSION GUIDE 254 12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 256 12.4 AVAILABLE CUSTOMIZATIONS 256 12.5 RELATED REPORTS 257
List Of Tables TABLE 1 GLOBAL LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION) 64 TABLE 2 GLOBAL CHROMATOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 65 TABLE 3 GLOBAL CHROMATOGRAPHY MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 66 TABLE 4 LIQUID CHROMATOGRAPHY MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 69 TABLE 5 GAS CHROMATOGRAPHY MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 70 TABLE 6 OTHER CHROMATOGRAPHY TECHNIQUES MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 71 TABLE 7 GLOBAL ELECTROPHORESIS MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION) 73 TABLE 8 ELECTROPHORESIS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 73 TABLE 9 GEL ELECTROPHORESIS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 75 TABLE 10 CAPILLARY ELECTROPHORESIS MARKET SIZE, BY REGION, 2012- 2019 ($MILLION) 76 TABLE 11 GLOBAL DNA SEQUENCERS & AMPLIFIERS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 77 TABLE 12 GLOBAL DNA SEQUENCERS & AMPLIFIERS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 77 TABLE 13 DNA SEQUENCERS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 80 TABLE 14 GLOBAL DNA AMPLIFIERS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 81 TABLE 15 DNA AMPLIFIERS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 82 TABLE 16 THERMO CYCLERS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 82 TABLE 17 REAL-TIME PCR MARKET SIZE, BY REGION, 2012- 2019 ($MILLION) 83 TABLE 18 OTHER AMPLIFIERS MARKET SIZE, BY REGION, 2012- 2019 ($MILLION) 84 TABLE 19 GLOBAL LAB AUTOMATION MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 85 TABLE 20 LAB AUTOMATION MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 86 TABLE 21 AUTOMATED LIQUID HANDLING MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 88 TABLE 22 MICROPLATE READERS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 89 TABLE 23 STANDALONE ROBOTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 89 TABLE 24 AUTOMATED STORAGE AND RETRIEVAL SYSTEMS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 90 TABLE 25 SOFTWARE AND INFORMATICS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 92 TABLE 26 OTHER LAB AUTOMATION EQUIPMENT AND SOFTWARE MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 92 TABLE 27 GLOBAL SPECTROSCOPY MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION) 94 TABLE 28 SPECTROSCOPY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 94 TABLE 29 MOLECULAR SPECTROSCOPY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 97 TABLE 30 ATOMIC SPECTROSCOPY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 98 TABLE 31 MASS SPECTROMETRY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 99 TABLE 32 IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION) 101 TABLE 33 IMMUNOASSAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 101 TABLE 34 ENZYME IMMUNOASSAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 106 TABLE 35 FLUORESCENCE IMMUNOASSAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 106 TABLE 36 CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 107 TABLE 37 RADIOIMMUNOASSAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 108 TABLE 38 OTHER IMMUNOASSAYS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 109 TABLE 39 GLOBAL MICROARRAY MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 110 TABLE 40 MICROARRAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 111 TABLE 41 DNA MICROARRAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 112 TABLE 42 PROTEIN MICROARRAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 113 TABLE 43 TISSUE MICROARRAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 113 TABLE 44 CELL MICROARRAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 114 TABLE 45 GLOBAL FLOW CYTOMETRY MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION) 115 TABLE 46 FLOW CYTOMETER ARRAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 116 TABLE 47 CELL-BASED FLOW CYTOMETRY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 119 TABLE 48 BEAD-BASED FLOW CYTOMETRY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 120 TABLE 49 OTHER FLOW CYTOMETRY TECHNOLOGIES MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 120 TABLE 50 GLOBAL OTHER INSTRUMENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 121 TABLE 51 OTHER INSTRUMENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 122 TABLE 52 CENTRIFUGES MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 122 TABLE 53 LABORATORY BALANCES MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 123 TABLE 54 INCUBATORS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 124 TABLE 55 FUME HOODS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 125 TABLE 56 GLOBAL CHROMATOGRAPHY MARKET SIZE, BY END USER, 2012–2019 ($MILLION) 128 TABLE 57 GLOBAL ELECTROPHORESIS MARKET SIZE, BY END USER, 2012–2019 ($MILLION) 133 TABLE 58 GLOBAL DNA SEQUENCERS & AMPLIFIERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION) 136 TABLE 59 GLOBAL LAB AUTOMATION MARKET SIZE, BY END USER, 2012–2019 ($MILLION) 138 TABLE 60 GLOBAL SPECTROSCOPY MARKET SIZE, BY END USER, 2012–2019 ($MILLION) 141 TABLE 61 GLOBAL IMMUNOASSAYS MARKET SIZE, BY END USER, 2012–2019 ($MILLION) 146 TABLE 62 GLOBAL MICROARRAYS MARKET SIZE, BY END USER, 2012–2019 ($MILLION) 148 TABLE 63 GLOBAL FLOW CYTOMETRY MARKET SIZE, BY END USER, 2012–2019 ($MILLION) 151 TABLE 64 GLOBAL OTHER INSTRUMENTATION MARKET SIZE, BY END USER, 2012–2019 ($MILLION) 154 TABLE 65 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 157 TABLE 66 NORTH AMERICA: LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 162 TABLE 67 NORTH AMERICA: CHROMATOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 162 TABLE 68 NORTH AMERICA: ELECTROPHORESIS MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 163 TABLE 69 NORTH AMERICA: DNA SEQUENCERS & AMPLIFIERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION) 163 TABLE 70 NORTH AMERICA: LAB AUTOMATION MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION) 163 TABLE 71 NORTH AMERICA: SPECTROSCOPY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 164 TABLE 72 NORTH AMERICA: IMMUNOASSAYS MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 164 TABLE 73 NORTH AMERICA: MICROARRAYS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION) 165 TABLE 74 NORTH AMERICA: FLOW CYTOMETRY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 165 TABLE 75 NORTH AMERICA: OTHER INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION) 165 TABLE 76 EUROPE: LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 169 TABLE 77 EUROPE: CHROMATOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 169 TABLE 78 EUROPE: ELECTROPHORESIS MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 170 TABLE 79 EUROPE: DNA SEQUENCERS & AMPLIFIERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION) 170 TABLE 80 EUROPE: LAB AUTOMATION MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION) 170 TABLE 81 EUROPE: SPECTROSCOPY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 171 TABLE 82 EUROPE: IMMUNOASSAYS MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 171 TABLE 83 EUROPE: MICROARRAYS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION) 171 TABLE 84 EUROPE: FLOW CYTOMETRY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 172 TABLE 85 EUROPE: OTHER INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION) 172 TABLE 86 ASIA-PACIFIC: LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION) 177 TABLE 87 ASIA-PACIFIC: CHROMATOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 177 TABLE 88 ASIA-PACIFIC: ELECTROPHORESIS MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 178 TABLE 89 ASIA-PACIFIC: DNA SEQUENCERS & AMPLIFIERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION) 178 TABLE 90 ASIA-PACIFIC: LAB AUTOMATION MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION) 178 TABLE 91 ASIA-PACIFIC: SPECTROSCOPY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 179 TABLE 92 ASIA-PACIFIC: IMMUNOASSAYS MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 179 TABLE 93 ASIA-PACIFIC: MICROARRAYS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION) 180 TABLE 94 ASIA-PACIFIC: FLOW CYTOMETRY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 180 TABLE 95 ASIA-PACIFIC: OTHER INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION) 180 TABLE 96 ROW: LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 182 TABLE 97 ROW: CHROMATOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 183 TABLE 98 ROW: ELECTROPHORESIS MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 183 TABLE 99 ROW: DNA SEQUENCERS & AMPLIFIERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION) 183 TABLE 100 ROW: LAB AUTOMATION MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION) 184 TABLE 101 ROW: SPECTROSCOPY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 184 TABLE 102 ROW: IMMUNOASSAYS MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 185 TABLE 103 ROW: MICROARRAYS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION) 185 TABLE 104 ROW: FLOW CYTOMETRY MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION) 185 TABLE 105 ROW: OTHER INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION) 186 TABLE 106 TOP 5 NEW PRODUCT LAUNCHES, 2012–2014 189 TABLE 107 TOP 5 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2012–2014 190 TABLE 108 TOP 5 GEOGRAPHICAL EXPANSIONS, 2012–2014 191 TABLE 109 TOP 5 ACQUISITIONS, 2012–2014 193 TABLE 110 TOP 5 OTHER DEVELOPMENTS, 2012–2014 194
List Of Figures FIGURE 1 RESEARCH DESIGN 28 FIGURE 2 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, & REGION 30 FIGURE 3 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET: BOTTOM-UP APPROACH 32 FIGURE 4 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET: TOP-DOWN APPROACH 33 FIGURE 5 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET: DATA TRIANGULATION 34 FIGURE 6 GLOBAL LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, 2014 ($MILLION) 36 FIGURE 7 GLOBAL LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY TECHNOLOGY, 2014 VS. 2019 38 FIGURE 8 GLOBAL LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY REGION, 2014 ($MILLION) 39 FIGURE 9 EMERGING COUNTRIES OFFER HIGH GROWTH OPPORTUNITIES TO PLAYERS IN THE LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET 41 FIGURE 10 ASIA-PACIFIC DNA SEQUENCERS AND AMPLIFIERS MARKET OFFERS LUCRATIVE GROWTH OPPORTUNITIES FOR PLAYERS 42 FIGURE 11 SPECTROSCOPY DOMINATES THE GLOBAL LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET ACROSS ALL GEOGRAPHIC REGIONS 43 FIGURE 12 SPECTROSCOPY SEGMENT WILL CONTINUE TO DOMINATE THE LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET IN 2019 44 FIGURE 13 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SEGMENTATION 46 FIGURE 14 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY TECHNOLOGY 47 FIGURE 15 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SEGMENTATION, BY END USER 48 FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 49 FIGURE 17 INCREASING GOVERNMENT SPENDING ON PHARMACEUTICAL R&D IN EMERGING NATIONS IS PROPELLING THE MARKET GROWTH 51 FIGURE 18 HIGH COST OF TECHNOLOGICALLY ADVANCED INSTRUMENTS LIMITS THEIR ADOPTION AMONG LOW-BUDGET END USERS 53 FIGURE 19 EMERGING COUNTRIES ARE OFFERING LUCRATIVE GROWTH OPPORTUNITIES FOR MARKET PLAYERS 55 FIGURE 20 VALUE CHAIN OF LIFE SCIENCE AND CHEMICAL INSTRUMENTATION INDUSTRY 58 FIGURE 21 PORTER’S FIVE FORCES ANALYSIS 60 FIGURE 22 LIQUID CHROMATOGRAPHY SEGMENT ACCOUNTED FOR THE LION’S SHARE OF THE GLOBAL CHROMATOGRAPHY MARKET IN 2014 65 FIGURE 23 GLOBAL CHROMATOGRAPHY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2014 72 FIGURE 24 GEL ELECTROPHORESIS HELD THE LARGEST SHARE OF THE GLOBAL ELECTROPHORESIS MARKET IN 2014 73 FIGURE 25 DNA SEQUENCERS AND AMPLIFIERS MARKET IS POISED TO GROW AT A DOUBLE-DIGIT CAGR FROM 2014 TO 2019 76 FIGURE 26 BURGEONING PREVALENCE OF HIV WORLDWIDE WILL BOOST THE ADOPTION OF PCR 79 FIGURE 27 GLOBAL DNA SEQUENCERS MARKET SHARE, BY KEY PLAYER, 2014 81 FIGURE 28 MICROPLATE READERS ARE THE FASTEST-GROWING SEGMENT IN THE GLOBAL LAB AUTOMATION MARKET 85 FIGURE 29 INFORMATION FLOW PYRAMID 91 FIGURE 30 GLOBAL LAB AUTOMATION MARKET SHARE, BY KEY PLAYER, 2014 93 FIGURE 31 MOLECULAR SPECTROSCOPY SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL SPECTROSCOPY MARKET IN 2019 93 FIGURE 32 GLOBAL MOLECULAR SPECTROSCOPY MARKET SHARE, BY KEY PLAYER, 2014 97 FIGURE 33 GLOBAL ATOMIC SPECTROSCOPY MARKET SHARE, BY KEY PLAYER, 2014 98 FIGURE 34 GLOBAL MASS SPECTROMETRY MARKET SHARE, BY KEY PLAYER, 2014 100 FIGURE 35 ENZYME IMMUNOASSAYS SEGMENT DOMINATED THE GLOBAL IMMUNOASSAY MARKET IN 2014 100 FIGURE 36 GLOBAL PREVALENCE OF CANCER 102 FIGURE 37 GLOBAL DISTRIBUTION OF CARDIOVASCULAR MORTALITY RATES AMONG MALES, 2011 103 FIGURE 38 GLOBAL DISTRIBUTION OF CARDIOVASCULAR MORTALITY RATES AMONG FEMALES, 2011 104 FIGURE 39 GLOBAL IMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2014 109 FIGURE 40 OVER 50% OF THE MICROARRAY MARKET WAS DOMINATED BY DNA MICROARRAYS IN 2014 110 FIGURE 41 CELL-BASED FLOW CYTOMETRY SEGMENT DOMINATES THE FLOW CYTOMETRY MARKET 115 FIGURE 42 GLOBAL FLOW CYTOMETRY MARKET SHARE, BY KEY PLAYER, 2014 121 FIGURE 43 PHARMACEUTICAL COMPANIES AND CROS HOLD THE LARGEST SHARE OF CHROMATOGRAPHY END USERS MARKET 128 FIGURE 44 FORENSIC SCIENCE AND CLINICAL DIAGNOSTIC LABORATORIES ARE THE MAJOR END USERS OF ELECTROPHORESIS DEVICES 132 FIGURE 45 HOSPITALS AND DIAGNOSTIC CENTERS ARE THE FASTEST-GROWING END-USER SEGMENT OF THE DNA SEQUENCERS AND AMPLIFIERS MARKET 135 FIGURE 46 THE ADOPTION OF LAB AUTOMATION SOLUTIONS IS INCREASING RAPIDLY AMONG RESEARCH INSTITUTIONS 138 FIGURE 47 PHARMACEUTICAL COMPANIES AND CROS COMMAND THE LARGEST SHARE OF THE GLOBAL SPECTROSCOPY END USERS MARKET 141 FIGURE 48 HOSPITALS ARE THE MAJOR END USERS OF THE IMMUNOASSAYS MARKET 145 FIGURE 49 PHARMA AND BIOPHARMA INDUSTRIES DOMINATE THE MICROARRAY INSTRUMENTATION END USERS MARKET 148 FIGURE 50 CLINICAL TESTING LABS IS THE FASTEST-GROWING SEGMENT OF THE FLOW CYTOMETRY END USERS MARKET 150 FIGURE 51 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 156 FIGURE 52 AVAILABILITY OF LIFE SCIENCE RESEARCH FUNDING IS DRIVING THE MARKET GROWTH 158 FIGURE 53 EUROPEAN LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SNAPSHOT (2014-2019): DIRECT AND INDIRECT INVESTMENTS IN ANALYTICAL INSTRUMENTS ARE DRIVING THE MARKET GROWTH 166 FIGURE 54 ASIA-PACIFIC LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SNAPSHOT (2014-2019): KEY PLAYERS ARE STRATEGICALLY EXPANDING THEIR PRESENCE IN THIS EMERGING MARKET 173 FIGURE 55 LEADING MARKET PLAYERS ADOPTED NEW PRODUCT LAUNCHES AS THEIR KEY GROWTH STRATEGY IN 2014 188 FIGURE 56 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES IS THE KEY STRATEGY 189 FIGURE 57 GEOGRAPHIC REVENUE MIX OF TOP 5 MARKET PLAYERS 195 FIGURE 58 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT 196 FIGURE 59 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 204 FIGURE 60 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT 208 FIGURE 61 BRUKER CORPORATION: COMPANY SNAPSHOT 213 FIGURE 62 DANAHER CORPORATION: COMPANY SNAPSHOT 218 FIGURE 63 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT 224 FIGURE 64 PERKINELMER, INC.: COMPANY SNAPSHOT 228 FIGURE 65 SHIMADZU CORPORATION: COMPANY SNAPSHOT 233 FIGURE 66 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT 239 FIGURE 67 WATERS CORPORATION: COMPANY SNAPSHOT 247
Enquiry Before Buy
image
Can´t read the image ? refresh here.